|
WEE1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.182200E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.724000E-03 |
| Normal-vs-Stage2 |
6.573500E-04 |
| Normal-vs-Stage3 |
1.9651599999948E-05 |
| Normal-vs-Stage4 |
1.48649999998085E-06 |
| Stage1-vs-Stage2 |
2.192400E-01 |
| Stage1-vs-Stage3 |
9.035000E-03 |
| Stage1-vs-Stage4 |
5.594600E-04 |
| Stage2-vs-Stage3 |
3.636200E-01 |
| Stage2-vs-Stage4 |
1.381030E-01 |
| Stage3-vs-Stage4 |
4.593400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.203700E-04 |
| Normal-vs-AfricanAmerican |
1.309770E-01 |
| Normal-vs-Asian |
1.854150E-02 |
| Caucasian-vs-AfricanAmerican |
3.123200E-01 |
| Caucasian-vs-Asian |
8.781200E-01 |
| AfricanAmerican-vs-Asian |
5.238000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.446080E-04 |
| Normal-vs-Female |
5.016600E-04 |
| Male-vs-Female |
4.877800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.383000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.576700E-04 |
| Normal-vs-Age(61-80Yrs) |
1.607550E-04 |
| Normal-vs-Age(81-100Yrs) |
4.184700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.919600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.229400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.925800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.680600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.277400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.470200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.087800E-01 |
| Normal-vs-Grade 2 |
1.263670E-02 |
| Normal-vs-Grade 3 |
1.80082999999831E-05 |
| Normal-vs-Grade 4 |
1.51410000004404E-06 |
| Grade 1-vs-Grade 2 |
8.425000E-01 |
| Grade 1-vs-Grade 3 |
6.106200E-02 |
| Grade 1-vs-Grade 4 |
2.031800E-02 |
| Grade 2-vs-Grade 3 |
2.737000E-03 |
| Grade 2-vs-Grade 4 |
4.436600E-04 |
| Grade 3-vs-Grade 4 |
2.442800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.717220E-03 |
| Normal-vs-ccB subtype |
1.439340E-03 |
| ccA subtype-vs-ccB subtype |
4.365600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.414000E-04 |
| Normal-vs-N1 |
4.47869999975481E-08 |
| N0-vs-N1 |
1.056590E-03 |
|
|
